This site is intended for healthcare professionals

Phase III VERTIS CV trial with Steglatro meets endpoint in type 2 diabetes + CV.- Merck Inc and Pfizer

Read time: 1 mins
Last updated:17th Jun 2020
Published:17th Jun 2020
Condition: Diabetes Type 2 + CV Disease
Type: drug
Register free for full access to